Charles River Laboratories | CRL - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Agilent USD 2.29B 20M 2026-06
Align Technology USD 1.91B 2.74M 2026-06
Bio-Rad Laboratories USD 961.3M 44.3M 2026-06
Bruker USD 1.2B 150.4M 2026-06
Cardinal Health USD 43.9B 1.92B 2026-06
Charles River Laboratories USD 1.13B 41.04M 2026-06
Cigna USD 55.56B 2.96B 2026-06
Concord Medical Services Hldg CNY 1.95B 499.89M 2025-12
CVS Health USD 87.04B 635M 2026-06
Danaher USD 8.1B 645M 2026-06
Dentsply International USD 1.18B 22M 2026-06
Elevance Health USD 44.25B 1.06B 2026-06
Humana USD 21.51B 5.16B 2026-03
Illumina USD 1.58B 12M 2026-06
Incyte USD 1.31B 177.55M 2026-06
Intrexon USD 23.02M 38K 2024-06
IQVIA Holdings USD 8.82B 486M 2026-06
Laboratory Of America USD 2.12B 516.4M 2026-06
Lakefront Biotherapeutics EUR 70.32M 30.1M 2026-06
Lonza CHF 3.57B 421M 2025-12
McKesson USD 70.36B 3.34B 2026-06
Merck EUR 8.12B 1.22B 2026-06
Mettler Toledo International USD 1.2B 92.14M 2026-06
Novartis USD 31.75B 374M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Quest Diagnostics USD 1.79B 389M 2026-06
Revvity USD 1.28B 37.71M 2026-06
Thermo Fisher Scientific USD 15.07B 448M 2026-06
United Therapeutics USD 607.8M 8.7M 2026-06
UnitedHealth USD 111.82B 2.3B 2026-06
Veradigm USD 230.31M 22.78M 2022-12
Waters USD 2.27B 1.03B 2026-03
West Pharmaceutical Services USD 640.5M 33.5M 2026-06